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ABSTRACT A fundamental goal of contemporary biomedical research is to under-
stand the molecular basis of disease pathogenesis and exploit this information to
develop targeted and more-effective therapies. Necrotizing myositis caused by the
bacterial pathogen Streptococcus pyogenes is a devastating human infection with a
high mortality rate and few successful therapeutic options. We used dual transcrip-
tome sequencing (RNA-seq) to analyze the transcriptomes of S. pyogenes and host
skeletal muscle recovered contemporaneously from infected nonhuman primates.
The in vivo bacterial transcriptome was strikingly remodeled compared to organisms
grown in vitro, with significant upregulation of genes contributing to virulence and
altered regulation of metabolic genes. The transcriptome of muscle tissue from in-
fected nonhuman primates (NHPs) differed significantly from that of mock-infected
animals, due in part to substantial changes in genes contributing to inflammation
and host defense processes. We discovered significant positive correlations between
group A streptococcus (GAS) virulence factor transcripts and genes involved in the
host immune response and inflammation. We also discovered significant correlations
between the magnitude of bacterial virulence gene expression in vivo and pathogen
fitness, as assessed by previously conducted genome-wide transposon-directed in-
sertion site sequencing (TraDIS). By integrating the bacterial RNA-seq data with the
fitness data generated by TraDIS, we discovered five new pathogen genes, namely,
S. pyogenes 0281 (Spy0281 [dahA]), ihk-irr, slr, isp, and ciaH, that contribute to necro-
tizing myositis and confirmed these findings using isogenic deletion-mutant strains.
Taken together, our study results provide rich new information about the molecular
events occurring in severe invasive infection of primate skeletal muscle that has ex-
tensive translational research implications.
IMPORTANCE Necrotizing myositis caused by Streptococcus pyogenes has high mor-
bidity and mortality rates and relatively few successful therapeutic options. In addi-
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tion, there is no licensed human S. pyogenes vaccine. To gain enhanced understand-
ing of the molecular basis of this infection, we employed a multidimensional
analysis strategy that included dual RNA-seq and other data derived from experi-
mental infection of nonhuman primates. The data were used to target five strepto-
coccal genes for pathogenesis research, resulting in the unambiguous demonstration
that these genes contribute to pathogen-host molecular interactions in necrotizing
infections. We exploited fitness data derived from a recently conducted genome-
wide transposon mutagenesis study to discover significant correlation between the
magnitude of bacterial virulence gene expression in vivo and pathogen fitness. Col-
lectively, our findings have significant implications for translational research, poten-
tially including vaccine efforts.
KEYWORDS bacterial pathogenesis, bacterial virulence, dual RNA-seq, necrotizing
fasciitis, pathogen-host interaction, Streptococcus pyogenes
Molecular interaction between a pathogen and its host can result in asymptomaticcarriage and disease and, sometimes, death. Regardless of the ultimate outcome,
an important aspect of pathogen and host interaction is that changes in gene tran-
scription shape complex phenotypes such as site of infection, pathogen dissemination,
and disease severity. Thus, a fuller understanding of the infection cycle and disease
mechanisms requires analysis of molecular events occurring contemporaneously in a
pathogen and host.
Streptococcus pyogenes, also known as group A streptococcus (GAS), is a strict
human pathogen responsible for 700 million infections and 517,000 deaths annu-
ally worldwide (1). This organism causes diverse infections that range in severity from
relatively mild conditions such as pharyngitis to life-threatening septicemia and necro-
tizing fasciitis/myositis (2). GAS has been classified historically based on sequence
variation in the emm gene encoding M protein, a cell-surface molecule that is an-
tiphagocytic and an important virulence factor (3). Whereas the majority of invasive
infections in North America and Europe are caused by a relatively small number of emm
types, for example, emm1, emm3, emm12, and emm28 (4–11), strains of these serotypes
are relatively rare in high-disease-burden, low-income regions. Despite a century of
effort by many investigators, there is no licensed vaccine available to protect humans
against GAS disease.
GAS is a primary cause of bacterial necrotizing fasciitis/myositis, an infection that is
associated with remarkably high rates of morbidity and mortality. Many different M
protein types of GAS can cause deep-tissue necrotizing infections, but strains of M1 are
especially prominent. As with many GAS infections, the molecular pathogenesis of
necrotizing myositis is complex, with many bacterial molecules implicated. Research
over many years has shown that a broad array of secreted and surface-displayed
virulence molecules contribute to infection pathogenesis, including but not limited to
M protein, cytolytic toxins such as streptolysin O and streptolysin S, degradative
enzymes (e.g., streptococcal pyrogenic toxin B cysteine protease, C5a peptidase, and an
IgG-cleaving enzyme), and a hyaluronic acid capsule. Although progress has been made
in understanding mechanisms contributing to necrotizing infections, much remains to
be learned.
To further vaccine and other translational research efforts, several studies have been
conducted to elucidate virulence determinants expressed in vivo during different types
of infections (12–16). Initial studies measuring gene expression during the interaction
of GAS with its host were performed with hybridization approaches that involved
custom-made Affymetrix gene chips (17–20). For example, Graham et al. (17) studied
GAS genes expressed during experimental soft tissue infection in mice. In addition, in
a large study involving 20 nonhuman primates (NHPs), Virtaneva et al. (20) described
GAS gene transcript changes that occurred over a 84-day infection cycle that involved
initial colonization of the upper respiratory tract (URT), clinical pharyngitis, and subse-
quent asymptomatic carriage. Similarly, Shea et al. (18) analyzed the complicated
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relationship between changes in GAS and host NHP transcripts over the URT infection
cycle. These and other studies have provided much new data about GAS interactions
with the host during invasive and URT infection, but knowledge gaps remain.
Dual transcriptome sequencing (RNA-seq) (21) has afforded the ability to determine
transcriptome changes using deep-sequencing technologies, and this technique has
been exploited using wild-type strains of multiple GAS serotypes and mutant strains in
which different virulence regulators have been inactivated (22–28). Recent develop-
ment of dual RNA-seq analysis has assisted studies designed to measure transcripts of
both pathogen and host during infection (29–32). Most dual RNA-seq studies have used
host cell lines to analyze pathogen-host interactions (33–40), resulting in new infor-
mation about the interplay between the two. However, these experiments share the
inherent limitation that cell culture infection models exclude the influence of many
host factors and thus are limited compared to the intact-animal milieu. A few studies
have used mouse infection models of human pathogens, including work done with
Pseudomonas aeruginosa (41), Staphylococcus aureus (42), Clostridium perfringens (43),
and Yersinia pseudotuberculosis (44). However, dual RNA-seq work has not been con-
ducted with an NHP experimental infection model and a human-restricted pathogen.
In the present study, we used a well-described NHP model of necrotizing myositis
(27, 45, 46) and dual RNA-seq to study the relationship between pathogen and host
transcripts. Until now, a limited number of studies have been conducted using dual
RNA-seq under in vivo conditions (41, 42, 47–53). In a very recent study, dual RNA-seq
was performed on human tissue biopsiy samples obtained from necrotizing soft tissue
infections (54). Here, the GAS RNA-seq data were integrated with fitness data generated
previously by a genome-wide transposon mutagenesis screen in necrotizing myositis
(46) to select genes for further study. We subsequently created isogenic mutant strains
and confirmed the pathogenesis role of five genes not previously known to contribute
to necrotizing myositis. In the aggregate, use of this multidimensional investigative
strategy resulted in discovery of new genes with important roles in virulence during
necrotizing myositis in primates.
RESULTS
Altered transcript regulation of GAS during deep skeletal muscle infection in
NHPs. We first examined the relationship between the transcript profiles of GAS strains
grown in rich Todd-Hewitt broth supplemented with yeast extract (THY) (classified as
grown in vitro) and organisms isolated from infected skeletal muscle tissue from NHPs
(classified as grown in vivo). We hypothesized that the transcript pattern of GAS
recovered from infected NHP skeletal muscle tissue is significantly different from the
transcript pattern of bacteria grown in vitro. This matter is important because the data
could be exploited to identify previously undefined genes and mechanisms used by
GAS during deep-muscle necrotizing invasive disease.
To address this issue, we infected NHPs with serotype M1 strain MGAS2221, an
organism genetically representative of strains causing a recent global pandemic of
invasive infections (27). This strain had been used previously in NHP necrotizing
myositis studies (46, 55). Sections from infected skeletal muscle tissue and uninfected
controls were processed 24 h postinoculation following a standard procedure required
by our approved NHP infection protocol (46, 55), and GAS transcript data were obtained
by RNA-seq. Between 5  108 and 2.1  109 total transcript reads were obtained from
each animal (Fig. 1A). Reads mapping to both GAS and NHP genomes constituted a
negligible proportion and were excluded from further analysis. The distribution of reads
mapping either to the GAS genome or to the genome of mock-infected or infected
NHPs is shown in Fig. 1B and C. Importantly, there was very high correlation (R2 range,
0.87 to 0.99) between the biological replicates, comparing either the in vitro GAS
samples analyzed in triplicate or the pooled in vivo GAS samples for each NHP (see
Table S1A in the supplemental material). Similarly, the correlation was very high (R2
range, 0.94 to 0.96) for the infected and mock-infected NHP samples (Table S1A).
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Consistent with our hypothesis that the transcriptome of GAS grown in vivo in
skeletal muscle is substantially different from that of GAS grown in vitro, three distinct
clusters were identified by principal component analysis (PCA), corresponding to GAS
samples from strains grown in vitro collected at either the mid-exponential (ME) or the
early stationary (ES) growth phase and strains obtained from the infected NHPs (in vivo)
(see Fig. S1A in the supplemental material). We collected tissue sections in a concentric
fashion with respect to the central inoculation site for the purpose of analyzing
transcript changes based on spatial distribution (Fig. S2A). The central inoculation site
had higher levels of edema, necrosis, and neutrophils and a higher bacterial load than
the more distal sections with fewer GAS bacteria, as shown by CFU counts and
consistent with previous data (46). When the in vivo samples taken from each section
were not pooled prior to PCA, tighter clustering was evident only for section 1,
corresponding to the central inoculation site (Fig. S1B and C). The NHP samples


















































































FIG 1 Mapping of transcript reads from in vivo samples to GAS and NHP genomes. Numbers of transcript
reads per sample are shown. (A) Total number of sequence reads corresponding to each of the three
NHPs (hatched columns). Reads simultaneously mapping to both NHP and GAS genomes were excluded
(inset). Solid columns represent filtered reads, calculated by subtracting excluded reads from the total
number of transcript reads. (B) Number of transcript reads mapping to the reference GAS genome (strain
MGAS2221) corresponding to each of the three NHPs. (C) Number of transcript reads corresponding to
each of the three NHPs mapping to the NHP genome (http://useast.ensembl.org/Macaca_fascicularis/
Info/Annotation). The number of reads mapping to either the GAS genome (panel B) or the genome of
mock-infected or infected NHPs (panel C), respectively, was 7.0  105 (GAS) or 5.8  108/1.9  109 for
NHP-1, 1.0  106 (GAS) or 6.2  108/5.8  108 for NHP-2, and 2.5  106 (GAS) or 6.3  108/6.1  108 for
NHP-3.
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samples (Fig. S1D). Furthermore, analyzing pooled sections from the three NHPs, the
infected and mock-infected sections clustered separately and, as seen in the PCA, there
was a higher level of transcriptional variation among the infected sections than among
the mock-infected sections (Fig. S1E).
Inasmuch as the transcriptome groups were separated by PCA, we next used linear
discriminant analysis to identify genes that would enable effective differentiation
among the groups. We found that essentially every differentially expressed gene was
suitable for discriminating among the groups (data not shown). This result is consistent
with the clear separation of the groups identified by PCA.
Distinct GAS transcriptome landscape in NHP necrotizing myositis. The PCA
data indicated that the transcriptome of GAS recovered from the infected NHP skeletal
muscle differed markedly from that of GAS grown in vitro, regardless of whether the
comparator was ME-phase or ES-phase in vitro-grown organisms (Fig. 2A) (Table 1; see
also Table S1B, C, and D). Although transcript profile differences were identified
between each of the two growth phases and in vivo GAS, to conserve space, we have
concentrated on the description of common themes identified in the two data sets
considered in the aggregate (that is, ME and ES in vitro versus in vivo). Overall, 472
genes (29.8% of 1,584 coding genes, after excluding rRNA, tRNA, and phage genes)
were differentially expressed during in vivo infection (Fig. 2A), and 92.8% of those 472
genes had concordant differential expression, that is, were regulated in the same
direction in the ME and ES phases. Relative to GAS grown in vitro, we observed
upregulation of genes that encode stress genes, transcriptional regulators, virulence
factors, and membrane transporters, among others (Fig. 2B) (Fig. S2B; see also Ta-
ble S1B, C, and D). In addition, there was substantial alteration of transcripts from genes
encoding proteins that would reshape GAS energy metabolism. Highly expressed genes
encoding virulence factors and transcriptional regulators during in vivo infection are
shown in Fig. 3A and C. Genes encoding 52 transcriptional regulators were significantly
differentially expressed during in vivo compared to in vitro infection (Fig. 3D; see also
Table S1E). Several known transcriptional regulators that include two-component
regulatory systems were highly upregulated, including adcR (8-fold), ciaH and ciaR
(11-fold), and ihk-irr (11-fold). In addition, the transcript abundances of genes encoding
many virulence factors were increased (Fig. 3B; see also Table S1F). For example, 14
genes and/or operons involved in capsule synthesis, cytotoxicity, surface-associated
proteins/adhesins, and immune evasion were highly (5-fold) upregulated in vivo,
including the sagA-I operon (streptolysin S), slr (Listeria internalin A homolog), lmb
(encoding laminin binding protein), htpA (encoding a histidine triad protein), hasABC
(capsule synthesis genes), speA2, nga/ifs/slo, sclA, sic, spd3, spyA, mac, isp, speJ, the
streptin locus, and spnA (Fig. 3B). Similarly, genes that are involved in metal ion
homeostasis and which have a documented role in pathogenesis, including regulation
of iron (siaABC, shr, shp, and hupYZ) (56, 57), zinc (adcRBCA) (58, 59), and manganese
(mtsAB) (60), were upregulated (see Table S1F). Genes encoding enzymes in the
glycolytic pathway were downregulated, whereas genes encoding enzymes required
for the use of alternative carbon sources (Fig. S3A) and for mixed-acid fermentation
(Fig. S3B) were upregulated. Finally, genes likely involved in extracellular oxidative
stress defense were significantly upregulated (Fig. S3C).
Analysis of changes in the NHP transcriptome during GAS invasive infection.
We found that the transcriptomes from the skeletal muscle of NHPs infected with GAS
differed substantially from the transcriptomes from mock-infected NHP skeletal muscle
(Fig. S1D and E). Compared to mock-infected animals, 1,218 host genes were signifi-
cantly upregulated and 305 genes were downregulated (Table S2A). Genes encoding
proteins involved in the immune response, inflammation, and host defense were
significantly upregulated in tissue from infected NHPs (Table S2B). For example, genes
encoding cytokines (interleukin-1A [IL-1A], IL-1B, IL-6, IL-7, IL-10, IL-24, and IL-33) and
chemokines (CCL11, CCL20, CCL7, CXCL1, CXCL2, CXCL5, CXCL6, CXCL8, and CXCL16)
and matrix metalloproteases (MMP1, MMP8, MMP9, and MMP25) were upregulated. We
also observed upregulation of genes associated with polymorphonuclear leukocytes
Dual RNA-seq of S. pyogenes Primate Myositis ®
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FIG 2 Transcriptome signatures corresponding to GAS strains grown in vitro and in vivo. The heat map presents log-transformed normalized
transcript counts obtained under the following two experimental conditions: (i) GAS grown in rich medium (in vitro) and harvested at two
phases of growth (ME, mid-exponential; ES, early stationary) and (ii) GAS harvested from infected nonhuman primate (NHP) tissue (in vivo).
(Continued on next page)
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(PMNs) or neutrophils, cells that are important components of the early innate immune
response. For example, genes encoding proteins involved in recognition of bacterial
pathogens, such as pattern recognition receptors (e.g., CD14 and Toll-like receptors
[TLRs]); in recruitment of PMNs to the infection site (the gene encoding IL-8 was
upregulated by 1,000-fold); and in PMN degranulation and induction of the bactericidal
cascade (myeloperoxidase) and inflammatory cascade (IL-1, IL-1, IL-1RN, IL-6, IL-7,
IL-10, IL-24, IL-33, CCL11, CCL20, CCL7, CXCL1, CXCL2, CXCL5, CXCL6, CXCL8/IL-8,
CXCL16, and tumor necrosis factor alpha [TNF-]), were upregulated, perhaps as a
consequence of upregulation of TREM1 signaling (upregulated 287-fold, P  1.03E–15)
and additional pathogen receptors (Table S2A; see also Fig. S4A).
A prominent finding observed in the downregulated category was the identification
of genes encoding skeletal muscle and connective tissue proteins (Table S2B) such as
actin, myosin, tropomyosin, dystrophin, and troponin (Fig. S4A; see also Table S2A).
Together, these data are consistent with the substantial degree of tissue destruction
and necrotic muscle observed by detailed gross pathological examination of the
sections in GAS-infected animals (data not shown).
In addition to protein-coding genes, RNA transcripts for various long intergenic
noncoding RNAs (lincRNAs) and microRNAs (miRNAs) were differentially regulated in
the infected NHP tissue compared to mock-infected samples (Table S2A). Seven lin-
cRNAs and 12 microRNAs were significantly upregulated (9-fold to 500-fold and 4-fold
to 60-fold, respectively), and five (1 lincRNA and 4 miRNA) were downregulated.
MicroRNAs such as miR-221, miR-222, and miR-223 were significantly upregulated in
the infected host. Although their role in serious invasive GAS infection remains unexplored,
they have been reported to be involved in host immune response and inflammation
(61–63). Interestingly, microRNAs downregulated in infected host tissue, including miR-30A,
miR-133A1, and miR-1 and miR-2, participate in skeletal muscle development and function
(64, 65).
We compared the normalized read counts obtained from infected NHPs to the
normalized counts of human patient samples from monomicrobial infections caused by
S. pyogenes (n  12) recently published by Thänert et al. (54). We found that 87% of the
top 100 of the most highly transcribed genes from the infected NHPs were also highly
transcribed in the human patient samples. Moreover, among the highly transcribed
NHP genes (top 100), 50%, including S100A8, S100A9, CXCL8, HLA-A, NFKBIA, UBC,
FPR2, PTX3, and THBS1, were involved in stress response and inflammation. However,
a comparison of differential expression results from our study (NHP infected versus
mock infected) to their monomicrobial (S. pyogenes) patient data could not be per-
formed due to the unavailability of control samples (i.e., uninfected/healthy tissue)
samples in the study by Thänert et al. (54).
To test for a GAS-specific immune response in the host, we analyzed serum
biomarkers in infected and uninfected hosts. Of 17 serum biomarkers (cytokines,
chemokines, and other immune-related host molecules) tested by immunoassays (see
Text S1 in the supplemental material), we found 9 whose levels were significantly
increased in GAS-infected NHPs at 24 h postinoculation compared to preinfection
values (Fig. S5A). Importantly, the levels of 11 of these biomarkers were significantly
increased in serum from humans infected with GAS compared to healthy, uninfected
controls (Fig. S5B). Seven serum biomarkers were significantly increased in both NHP
and human cohorts. Taken together, these results are consistent with the NHP host
FIG 2 Legend (Continued)
The fold change value cutoff and adjusted P value cutoff were 1.5 and 0.05, respectively. (A) Heat map showing expression patterns of
genes (n  472) found to be significantly differentially expressed between in vitro and in vivo samples. Color coding is based on
log-transformed normalized count values; blue indicates lower transcript expression, and red indicates higher transcript expression. Also
indicated is hierarchical clustering of genes (dendrogram along the y axis) and of in vitro and in vivo GAS samples (dendrogram along the
x axis). (B) Heat map highlighting expression profile of genes (n  110) involved in GAS pathogenesis. Genes are assigned to three broad
categories: genes involved in virulence factors, genes encoding transcriptional regulators, and genes involved in responses to stress. Gene
names shown in red designate genes subsequently studied in more detail by constructing isogenic deletion-mutant strains.
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designationb Fold MEc Fold ESd
Capsule
Spy1851 hasA Hyaluronan synthase Spy1825 11.3 31.3
Spy1852 hasB UDP-glucose 6-dehydrogenase Spy1826 12.0 29.2
Spy1853 hasC UTP–glucose-1-phosphate uridylyltransferase Spy1827 5.9 10.5
Cytolysin/exotoxin
Spy0139 nga NAD glycohydrolase Spy0183 5.2 35.1
Spy0140 ifs Immunity factor for SPN Spy0184 6.1 30.1
Spy0141 slo Streptolysin O Spy0185 5.7 27.8
Spy0351 spyA c3 family ADP-ribosyltransferase Spy0403 7.4 11.5
Spy0562 sagA Streptolysin S precursor Spy0598 121.0 35.1
Spy0563 sagB Streptolysin S biosynthesis protein Spy0599 30.8 14.1
Spy0564 sagC Streptolysin S biosynthesis protein Spy0600 25.6 13.8
Spy0565 sagD Streptolysin S biosynthesis protein Spy0601 27.3 16.9
Spy0566 sagE Streptolysin S putative self-immunity protein Spy0602 26.2 17.0
Spy0567 sagF Streptolysin S biosynthesis protein Spy0603 21.2 13.7
Spy0568 sagG Streptolysin S export ATP-binding protein Spy0604 25.7 16.1
Spy0569 sagH Streptolysin S export transmembrane protein Spy0605 32.5 19.1
Spy0570 sagI Streptolysin S export transmembrane protein Spy0606 27.2 16.2
Secreted/immune evasion
Spy0668 mac IgG-degrading protease Spy0700 4.6 8.4
Spy0981 cfa CAMP factor Spy0993 5.2 NSf
Spy1169 spd3 Streptodornase Spy1179 5.3 19.4
Spy1415 sdaD2 Phage-encoded streptodornase Spy1430 2.9 4.6
Spy1684 ska Streptokinase Spy0254 NS 6.3
Spy1715 scpA C5A peptidase precursor Spy1697 NS 3.8
Spy1718 sic Streptococcal inhibitor of complement Spy1699 7.6 18.5
Spy1723 ispe Immunogenic secreted protein Spy1703 8.4 3.5
Spy1734 spi Streptopain protease inhibitor Spy1713 1,080.7 NS
Spy1735 speB Streptococcal pyrogenic exotoxin B Spy1714 912.3 NS
Spy1738 spd Phage-associated deoxyribonuclease Spy1717 70.5 NS
Superantigens
Spy0182 speG Exotoxin type G precursor Spy0222 2.1 3.8
Spy1702 smeZ Mitogenic exotoxin Z Spy0238 NS 2.6
Spy0356 speJ Exotoxin type J precursor Spy0408 4.1 5.9
Spy0996 speA2 Phage-encoded exotoxin Spy1009 20.4 21.8
Surface-associated/adhesins
Spy1711 lmb Laminin binding protein Spy0229 84.1 8.6
Spy1710 htp Streptococcal histidine triad protein Spy0230 80.5 8.5
Spy1687 sclA Collagen-like surface protein A Spy0251 NS 26.2
Spy0561 epf Putative extracellular matrix binding protein Spy0597 2.4 2.6
Spy0740 fbp Fibronectin-binding protein Spy0771 NS 2.1
Spy1109 slr Internalin protein Spy1122 54.1 48.6
Spy1719 emm1 M protein Spy1700 NS 2.1
Transcriptional regulators
Spy0947 ciaH TCSg histidine kinase Spy0962 10.2 8.4
Spy0948 ciaR TCS response regulator Spy0963 14.0 12.7
Spy1318 rocA TCS accessory protein Spy1324 2.3 2.3
Spy1720 mga Standalone regulator Spy1701 1.5 2.3
Spy1724 ihk TCS histidine kinase Spy1704 10.5 6.5
Spy1725 irr TCS response regulator Spy1705 16.1 10.2
Other
Spy0281 dahA Putative role in defense against stress Spy0340 NS 5.0
aGene designation for MGAS5005.
bGene designation for MGAS2221.
cFold differential expression comparing in vivo to in vitro ME samples.
dFold differential expression comparing in vivo to in vitro ES samples.
eGenes highlighted in bold were chosen for isogenic deletion-mutant strain generation.
fNS, not significant.
gTCS, two-component system.
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FIG 3 GAS virulence genes highly transcribed during in vivo infection and upregulated in vivo compared to in vitro. (A) Virulence factor genes that are highly
transcribed during in vivo infection are shown. Log-transformed mean expression (normalized) counts are plotted. Genes are considered highly transcribed if
their normalized expression values are in the top 75th percentile. (B) The y-axis values represent the mean fold change values determined from combined data
from the ME and ES in vitro growth phases. Both genes and operons are represented. The horizontal red line corresponds to 5-fold change, an arbitrarily chosen
level designed to highlight the magnitude of change. Virulence genes upregulated 5-fold are considered to be substantially upregulated. (C) Transcriptional
regulators highly transcribed during in vivo infection. Log-transformed mean expression (normalized) counts are plotted. (D) Transcriptional factors upregulated
during in vivo infection compared to in vitro growth. Fold change data from in vivo versus in vitro ME and ES comparisons were averaged, and log-transformed
mean log-fold changes are shown (y axis). Gene names shown in red designate genes subsequently studied in more detail by constructing isogenic
deletion-mutant strains. The fold change value cutoff and adjusted P value cutoff were 1.5 and 0.05, respectively.
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transcriptome data and suggest that the NHP model closely mimics the human
immune response to invasive GAS infection.
Pathogen-host gene correlation networks. To investigate possible pathogen-host
interactions based on our dual RNA-seq data, we used weighted gene coexpression
network analysis (WGCNA) (66) to cluster positively correlated genes into pathogen-
and host-specific network modules. On the basis of the normalized transcript counts of
the pathogen and the host genes, WGCNA grouped highly correlated genes into
clusters/modules. The GAS genes clustered into 15 pathogen modules and the NHP
genes into 10 host modules (Table S3A; see also Fig. S4B). A COG enrichment analysis
showed that GAS modules 5 and 6 were significantly enriched in genes involved in
carbohydrate transport/metabolism (COG category G; P value  0.000) and virulence
(COG category V; P value  0.006) and in posttranslation modification (COG category O;
P value  0.006) and virulence (COG category V; P value  0.000), respectively (Ta-
ble S3B). Moreover, an examination of the eigengene network showed that GAS
modules 5 and 6 were strongly positively correlated with three host gene modules
(modules 7, 8, and 9) involved in immune response, inflammation, and response to
stress (Table S3A), a result suggesting that upregulation of GAS virulence genes triggers
an immune response in the host. Conversely, GAS modules 5 and 6 were negatively
correlated with NHP modules involved in muscle development, contraction, mainte-
nance, and integrity (modules 1 to 4; see Table S3).
Dual RNA-seq identifies significant differences in spatially distinct transcrip-
tomes. Our experimental design permitted us to test the hypothesis that the GAS and
host transcriptomes differ as a function of distance from the inoculation site. To test this
hypothesis, we compared the GAS transcriptomes as a function of anatomic relation-
ship to the primary inoculation site. For this spatial (section-to-section) transcriptome
analysis, GAS read counts were pooled for each section from the three NHPs. Consistent
with the hypothesis, we found that the transcriptomes for sections 1 and 2 differed
substantially compared to the transcriptomes for sections 3 through 5 (Fig. 4A).
Combining the expression data from sections 1 and 2 (inoculation site) and comparing
it to that from pooled sections 3, 4, and 5 (distal site), we found 146 genes to be
differentially expressed, with a higher fraction of genes upregulated (62%) than
downregulated (38%) in the inoculation site than in the distal site (Table S1G). Various
virulence genes, including genes involved in immune evasion (htpA, lmb, sag operon,
sdaB, spd3, and spnA), metal ion homeostasis (htpA and lmb), tissue destruction (speB),
and cytotoxicity (sag operon), were upregulated, whereas grab, scfA, and scfB were
expressed at higher levels at the distal site than at the inoculation site (Fig. 4D). Genes
involved in DNA replication, recombination and repair (polA, exoA, topA, uvrA, mutY, and
ruvA), cell wall biogenesis (dacA and murA.2), and metabolic adaptation (malate, citrate,
and maltose utilization genes) were also differentially expressed. The data suggest that,
depending on location relative to a primary infection nidus, there is likely to be a
heterogeneous array of GAS transcriptomes in naturally occurring deep-tissue infection
in humans. We thus hypothesized that similar spatial trends might be observed in the
NHP transcriptome data.
On the basis of the overall expression profile of the NHP transcriptome, sections 1
to 4 clustered together compared to section 5 (most distal section from the inoculation
site) (Fig. 4B). Hence, we combined the expression data from sections 1 to 4, compared
the combined data to the data from section 5, and found 1,710 genes to be differen-
tially expressed. Pooled sections 1 to 4 showed significant upregulation of immune
response factors and of genes involved in defense and neutrophil activation and
degranulation and downregulation of genes involved in extracellular structure organi-
zation, indicative of reduced tissue integrity (Fig. 4E, top panel). In a different compar-
ison, NHP sections 1 and 2 (proximal to the inoculation site) were compared to sections
3, 4, and 5, and 899 genes were found to be differentially expressed. Interestingly, those
same genes alluded to above were also differentially expressed, although at a lower
fold change magnitude (Fig. 4E, bottom panel).
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FIG 4 Spatial analysis of GAS and NHP sections. (A) Hierarchical clustering of GAS transcript profiles from individual tissue sections
based on Euclidean distance. Data obtained from tissue sections 1 and 2 (closest to the inoculation site) are closely related and cluster
(Continued on next page)
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Genes contributing to GAS fitness in necrotizing myositis: integration of RNA-
seq and TraDIS data. A recent study using the same parental (wild-type) serotype M1
GAS strain (MGAS2221), experimental infection conditions, and transposon-directed
insertion site sequencing (TraDIS) method determined a fitness scale for all nonessen-
tial genes in NHP necrotizing myositis (46). The availability of these fitness data
permitted us to test the hypothesis that a significant relationship exists between the
magnitude of in vivo fitness (as assessed by TraDIS) and gene transcript remodeling.
This relationship has been studied to only a very limited extent in other pathogen-host
models, generally with somewhat ambiguous findings (67–69). Our analysis identified
a significant relationship between in vivo fitness and the in vitro RNA-seq data.
Comparison of GAS RNA-seq data obtained under in vivo conditions to those obtained
under in vitro conditions (ME and ES phases) found that 43% and 49.6%, respectively,
of fitness-related genes identified by TraDIS were significantly differentially expressed
(differential fold expression of 1.5). These results suggest that a sizeable proportion
of genes required for sustaining in vivo infection were responding to cues present in
host skeletal muscle, resulting in an altered transcript profile.
Of the fitness-conferring genes (i.e., genes that result in significantly decreased
fitness when insertionally inactivated) that are also upregulated in vivo compared to the
ME phase (n  43) or ES phase (n  51), we identified a significant correlation between
transcript fold change (log2; in vivo versus ME or ES phase, dual RNA-seq) and mutant
abundance fold change (log2; mutant frequency, TraDIS). The significant P values
computed using a 2-tailed test (Spearman rank correlation) were rs  1 and P  0 for
the TraDIS versus ES comparison and rs  0.99 and P  0 for the TraDIS versus ME
comparison (Fig. 5). Taken together, the data suggest that, on average, GAS genes that
are significantly upregulated in vivo are likely to be important to pathogen fitness. This
idea was tested using isogenic mutant strains and animal infection models as described
below.
Contribution of five new genes to necrotizing myositis virulence: analysis of
Spy0281, ihk-irr, slr, isp, and ciaH. In principle, the availability of the differential
expression data coupled with the TraDIS fitness data affords an enhanced opportunity
to exploit this combined information to gain greater understanding of the role of
specific genes in pathogen-host interactions, including virulence. There has been little
research of this type performed for microbial pathogens. In this context, we elected to
study five GAS genes that may participate in necrotizing myositis on the basis of our
results here (Table 1; see also Fig. 2, 3, and 5) by constructing isogenic deletion-mutant
strains. These five genes were selected based on four criteria: (i) each of the five genes
was substantially upregulated in vivo in the animal host compared to growth in vitro;
(ii) we had evidence from a previous genome-wide transposon mutagenesis study (46)
suggesting that these genes are important in pathogen-host interactions; (iii) the five
genes are all highly conserved among GAS strains; and (iv) no previous study had
tested the hypothesis that these genes contribute to necrotizing myositis. Due to cost
and other limitations, additional virulence factors were not tested in the present study.
First, we studied Spy0281 (here designated dahA, for defense against host protein A),
a gene that is differentially upregulated in infected NHPs relative to in vitro-grown
organisms, at the ME phase of growth. We selected dahA for analysis because (i) it is
FIG 4 Legend (Continued)
into one group, and data from sections 3, 4, and 5 cluster into a second distinct group. (B) NHP transcripts from infected tissue. Data
from sections 1, 2, 3, and 4 are closely related and cluster into one group. (C) NHP transcripts from infected and mock-infected tissue.
Data from all five sections from the mock-infected tissue, denoted by asterisks, are closely related and cluster into one group. In each
case, S1 through S5 correspond to data from analogous sections for the three NHPs pooled and analyzed together as individual units.
Each cluster is demarcated by a red perimeter. (D) Differentially expressed GAS virulence genes comparing pooled sections 1 and
2 to sections 3, 4, and 5. Twenty virulence genes were differentially expressed. The fold change value cutoff and adjusted P value
cutoff were 1.5 and 0.05, respectively. (E) Selected significantly upregulated immune response genes are depicted on the left, and
selected downregulated extracellular matrix organization and skeletal muscle development genes are shown on the right. (Top
panel) Comparison of pooled sections 1 through 4 to section 5. Bottom, comparison of pooled sections 1 and 2 to sections 3 through
5. The fold change value cutoff and adjusted P value cutoff were 1.5 and 0.05, respectively.
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FIG 5 Upregulated GAS genes that contribute to fitness during infection. The y axis represents the
product of the log-fold change (log-fold Δ) calculated as the product of in vivo fold change/in vitro fold
change, multiplied by the log-fold change calculated in a previous study using the same NHP experi-
mental methods and infecting GAS strain (46). The x axis is a linear representation of the GAS
chromosome. The size of the circles is proportionate to the product of the 2-fold changes. Red circles
(Continued on next page)
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located immediately upstream of genes encoding CovR and CovS, an intensively
studied gene regulatory two-component system (TCS) that directly or indirectly influ-
ences approximately 15% of the GAS transcriptome (70) (Fig. 6A); (ii) in a previous
TraDIS fitness screen, dahA was identified as being potentially important during NHP
necrotizing myositis (log2 fold change  6.7) (46), and (iii) DahA is homologous to
general stress proteins from several bacterial species, but its function in GAS is not
known. To test the hypothesis that dahA contributes to virulence, we created isogenic
deletion-mutant strain MGAS2221 ΔdahA and used it in a mouse model of necrotizing
myositis. The mutant and wild-type strains had similar growth curves in THY broth
(Fig. 6B). However, the mutant strain was significantly less virulent in this infection
model (Fig. 6C). Similarly, significantly fewer CFU of the mutant strain than of the
wild-type parental strain were cultured from the hindlimbs of infected mice (Fig. 6D),
and the resultant lesions were smaller (Fig. 6E). Consistent with the mouse infection
data, the isogenic mutant strain was significantly less able to survive exposure to
human blood and purified human polymorphonuclear leukocytes (PMNs) than the
wild-type parental strain (Fig. 6F). To gain additional information about the role of
dahA, we conducted RNA-seq analysis of the isogenic strains grown to the ME or ES
phase. We discovered that mutant strain MGAS2221 ΔdahA had a significantly altered
transcriptome compared with the wild-type parental strain (Fig. 6G). Importantly, 17
known virulence genes were significantly downregulated in the isogenic deletion-
mutant strain, consistent with the decreased virulence phenotype in the mouse model
(Table S1H). Thus, deletion of dahA significantly altered the transcriptome, including
transcript levels of many virulence genes, strain virulence in mice, and survival when
exposed to human PMNs (Fig. 6).
We next examined the role of the ihk-irr TCS (71) in necrotizing myositis. This TCS
was studied because (i) it was strikingly upregulated in vivo (Table S1); (ii) it is important
for GAS survival during infection (15, 72–74); (iii) it has been shown previously to be
involved in evasion of host innate immune responses, including PMN-mediated killing
(75); and (iv) it was identified as contributing to fitness in the TraDIS fitness screen in
NHP necrotizing myositis (46). However, the role of ihk-irr in necrotizing myositis has
not been addressed. To test the hypothesis that ihk-irr is involved in necrotizing
infection, isogenic mutant strain MGAS2221 Δihk-irr was used in the mouse model of
this disease. Consistent with the hypothesis, the results show that the deletion-mutant
strain was significantly less virulent than the wild-type parental strain (Fig. 6H).
We studied a third gene in the context of experimental NHP necrotizing myositis. slr
(Spy1109) encodes an extracellular protein with leucine-rich repeats that is homologous
to InlA in the Listeria monocytogenes internalin family of proteins (76). L. monocytogenes
InlA anchors the pathogen to the host cell surface by binding E-cadherin and may have
a role in bacterial internalization (77, 78). Slr has a domain with histidine triad motifs
that is predicted to bind divalent metal cations. Of note, slr was shown previously to be
significantly upregulated when GAS was grown under conditions of zinc starvation (59).
These observations suggest that slr is involved in zinc acquisition, a process known to
affect GAS virulence (58). We studied the GAS slr gene because (i) it was highly
upregulated in vivo in our dual RNA-seq data (Fig. 3B), (ii) it was identified as contrib-
uting to fitness by TraDIS analysis of NHP necrotizing myositis (46), (iii) serologic
analysis showed that Slr is expressed in vivo in humans with various types of GAS
infection (76), and (iv) its role in necrotizing myositis had not been addressed. To test
the hypothesis that Slr is involved in necrotizing infection, isogenic mutant strain
MGAS2221 Δslr was used in the mouse model of this disease. Consistent with the
FIG 5 Legend (Continued)
represent genes chosen for further study. Gene names shown in red designate genes subsequently
studied in more detail by constructing isogenic deletion-mutant strains. The fold change value cutoff and
adjusted P value cutoff were 1.5 and 0.05, respectively. (A) Genes upregulated in vivo compared to in
vitro ME growth phase. (B) Genes upregulated in vivo compared to in vitro in ES growth phase. (C) Genes
upregulated in vivo compared to in vitro in both ME and ES growth phases.
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FIG 6 Assessment of virulence of GAS isogenic mutant strains. (A) Schematic showing the Spy0281 (dahA) chromosomal region. dahA encodes
a putative stress-related protein, and covRS encode a two-component system (TCS) involved in virulence. The red arrow marks the transcriptional
start site for covRS (97). (B) Strains were grown at 37°C in THY medium. (C) Virulence of wild-type MGAS2221 and isogenic mutant MGAS2221
ΔdahA in a mouse model of necrotizing myositis (n  20 mice per strain). (D) CFU recovered from the inoculation site of mice. Replicate data
(n  35) are expressed as means  SEM. P  0.001, Mann-Whitney U test. (E) Representative gross images of mouse hindlimbs infected with the
strain MGAS2221 (left) and isogenic MGAS2221 ΔdahA strain (right). Lesion areas are boxed in white. Scale bar, 1 cm. (F) MGAS2221 and isogenic
mutant strain MGAS2221 ΔdahA exposed to purified human PMNs. Percent bacterial survival was assessed at 1 and 3 h as indicated. Means 
SEM of the data from 7 separate experiments are shown. (G) Total number of differentially expressed genes comparing wild-type parental strain
MGAS2221 and isogenic mutant strain MGAS2221 ΔdahA calculated using a fold cutoff value of 1.5 and a P value of 0.05. (H) Virulence of
(Continued on next page)
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hypothesis, results show that the deletion-mutant strain was significantly less virulent
than the wild-type parental strain (Fig. 6I).
We examined the potential contribution of the isp gene to necrotizing myositis. The
isp gene (encoding an immunogenic secreted protein, or Isp) is located immediately
downstream of the ihk-irr TCS and encodes a conserved 59-kDa GAS surface protein
that induces antibody responses in humans (79). Isp has a CHAP domain located at the
carboxy terminus, suggesting that it may be a peptidoglycan hydrolase with a potential
role in cell wall metabolism. However, the biological function of Isp is not known, nor
is it known if this protein contributes to necrotizing myositis. To test the hypothesis that
Isp is involved in necrotizing infection, isogenic mutant strain MGAS2221 Δisp was used
in the mouse model. Consistent with the hypothesis, results show that the deletion-
mutant strain was significantly less virulent than the wild-type parental strain (Fig. 6I).
The ciaH gene encodes the histidine kinase sensor protein of the CiaHR regulator
two-component system (TCS). ciaH has been reported to be involved in GAS responses
to acid and oxidative stresses (80). Interestingly, a previous virulence study found that
the ciaH deletion mutant was not attenuated in a mouse model of infection, but the
route of inoculation was not specified (80). We used the mouse model of necrotizing
myositis to test the hypothesis that deletion of ciaH significantly decreases virulence.
The results demonstrate that the ciaH isogenic deletion-mutant strain was significantly
attenuated in mice (Fig. 6I).
Inasmuch as GAS is a human-specific pathogen and the dahA, ihk-irr, slr, isp, and ciaH
virulence genes were identified in TraDIS and dual RNA-seq studies performed in NHPs,
we sought to confirm the role of each gene in necrotizing myositis using the NHP
model. The results showed that each isogenic deletion-mutant strain caused signifi-
cantly smaller lesions than the MGAS2221 parental wild-type parental strain (Fig. 6J),
with significantly lower CFU levels recovered from the infection site (Fig. 6K). These
results confirm a role of each of the five GAS genes in experimental necrotizing myositis
in primates.
DISCUSSION
Our understanding of the molecular mechanisms used by GAS to initiate and sustain
a severe invasive infection, especially during devastating cases of necrotizing myositis,
is limited. To address this knowledge deficit, we used a multidimensional investigative
strategy employing dual RNA-seq analysis of an extensively documented NHP model of
necrotizing myositis (27, 45, 46, 55), coupled with integration of TraDIS fitness data (46)
and analysis of isogenic deletion-mutant strains of GAS. Because GAS is a human-
specific pathogen, because NHPs are phylogenetically closely related to humans, and
because some GAS virulence factors are specific for human or NHP molecules, this
animal model best approximates human disease. Our studies identified five new GAS
genes encoding virulence factors that significantly contribute to necrotizing myositis.
The changes in the NHP transcriptome observed in infected compared to mock-
infected animals are consistent with the substantial degree of damaged tissue observed
in the animals. In the aggregate, our results significantly enhance understanding of the
complex molecular processes transpiring during pathogen-host interactions in necro-
tizing myositis, knowledge that can be exploited for subsequent basic and translational
research activities. A model summarizing the new pathogen and host data presented
in this work, together with selected previously reported findings bearing on the
molecular mechanisms at work in necrotizing myositis, is presented in Fig. 7.
Dual RNA-seq has been performed on a limited number of pathogens infecting
FIG 6 Legend (Continued)
wild-type MGAS2221 and isogenic mutant MGAS2221 Δihk-irr in a mouse model of necrotizing myositis (n  20 mice per strain). (I) Virulence
of wild-type MGAS2221 and isogenic mutant MGAS2221 Δslr, MGAS2221 Δisp, and MGAS2221 ΔciaH in a mouse model of necrotizing myositis
(n  20 mice per strain). (J) Virulence of wild-type and isogenic mutant strains (all derived from parental strain MGAS2221) in an NHP model of
necrotizing myositis (n  4 animals per strain). Lesion volume data are expressed as means  SEM. P  0.05, Kruskal-Wallis test. (K) Counts of
CFU recovered from the inoculation site of NHPs are expressed as means  SEM. P  0.05, Kruskal-Wallis test. All isogenic mutant strains were
derived from parental strain MGAS2221.
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FIG 7 Model of interaction of pathogen- and host-encoded factors to drive GAS-mediated necrotizing myositis pathology. GAS is well adapted to evade host
innate immune responses in NHPs and humans. The model is based on new data presented here and includes selected other GAS and host factors crucial for
various stages of invasive infection described in the literature, as detailed below. Note that not all pertinent genes and proteins could be included due to space
constraints. (A) GAS initiates an acute inflammatory response caused by host recognition of streptococcal components such as lipoteichoic acid and
peptidoglycan via extracellular (TLR1, TLR2, TLR4, TLR5, CR, TREM1, and FcR) and intracellular (TLR8) pattern recognition receptors. GAS subverts PMN activation
and recruitment by expressing many factors such as hyaluronic acid capsule and M protein and degrading host inflammatory mediators involved in PMN
recruitment. (B) GAS evades phagocytosis by producing many antiphagocytic factors (e.g., capsule, M protein). Phagocytosed GAS evade killing by PMNs by
secreting cytotoxins (SLO and SPN) and destroying PMNs migrating to the infection site (SLS). GAS-encoded secreted DNases attenuate antimicrobial activity
by degrading neutrophil extracellular traps (NETs). Other secreted factors such as streptococcal inhibitor of complement (SIC) and SpeB provide resistance to
host antimicrobial peptides (AMPs). In addition, GAS resists host-induced trace metal starvation by upregulating genes involved in acquisition of zinc, iron,
copper, and manganese. (C) Host cell destruction and tissue necrosis. GAS factors such as SLO, SLS, and SpeB directly damage cells and induce apoptosis and
(Continued on next page)
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intact hosts (48, 49, 53). In general, previous studies have focused predominantly on
descriptive analyses of the resulting data. That is, relatively little new proven gene-
specific mechanistic understanding has resulted. As a consequence, we opted to exploit
the pathogen transcript data integrated with our previous transposon mutagenesis
data to select genes for further analysis using isogenic deletion-mutant strains in
subsequent necrotizing myositis pathogenesis studies. Using this integrative and iter-
ative multidimensional strategy, we unambiguously demonstrated that five GAS genes
participate in this frequently fatal infection. For example, we showed that dahA
contributes to adaptation, fitness, and disease in this host environment (Fig. 6). The
dahA gene is located immediately upstream of covR and covS, an extensively studied
TCS (Fig. 6A) that regulates expression of approximately 15% of the GAS transcriptome
when grown in vitro (70). Consistent with CovRS being predominantly a negative gene
regulator, inactivation of covRS increases expression of many genes encoding key
virulence factors and enhances disease severity (19, 81). dahA is negatively regulated
(directly or indirectly) by covR, at both the ME and ES phases of growth (82). In addition,
dahA was identified as contributing to fitness in vivo during TraDIS analysis in an NHP
model of necrotizing myositis (46). Importantly, 39 genes encoding known virulence
factors were differentially expressed in vitro in the ΔdahA strain compared to the
wild-type parental strain (see Table S1H in the supplemental material). Additionally, we
found an overlap in upregulated genes between the MGAS2221 ΔdahA and MGAS2221
ΔcovR mutant strains (Table S1I), described in a previous study (82). Seventeen of these
genes were downregulated, including some with well-known critical roles in virulence,
including sic, emm, ropB, speB, hasABC, and mga. Thus, dahA has a complex role in
pathogen-host interaction, as many virulence genes are upregulated and many are
downregulated. The net effect of the differential in vivo gene regulation in a dahA
mutant is significantly decreased virulence in two animal models of necrotizing myo-
sitis. Additional research is under way to further investigate the role of dahA in GAS
molecular pathogenesis. Similarly, we demonstrated that the ihk-irr TCS (71) contributes
to necrotizing myositis. Our finding adds to previous work showing that this TCS is
important for GAS survival during infection, likely as a consequence of altering the
expression of multiple genes contributing to innate host defense (15, 72–74). In
addition, our data show that the slr gene encoding a GAS surface-displayed protein
with leucine-rich repeats participates in necrotizing myositis. We previously reported
that convalescence-phase serum samples from patients with GAS invasive infections,
soft tissue infections, pharyngitis, and rheumatic fever react with Slr (76), indicating that
this protein is expressed in vivo in infected humans. In the future, it will be important
to test the hypothesis that vaccination with one or more of these virulence factors can
elicit protective immunity in animal disease models. As stated previously, there is no
licensed human S. pyogenes vaccine. As a corollary to these studies, we will test whether
one or more of these five virulence factors are potential vaccine candidates via
protection studies in mouse or NHP models of infection.
Consistent with the likely situation in humans, we observed some variability in
differentially expressed GAS genes between the three NHPs (see Fig. S1D and E in the
supplemental material). However, importantly, the animal-to-animal variability was
largely due to variation in the magnitude of fold change in individual gene transcripts,
rather than to the spectrum of differentially expressed genes. Thus, for all NHPs, the in
vivo GAS transcriptome is very distinct from that in in vitro-grown cells, regardless of
growth phase.
FIG 7 Legend (Continued)
necrosis via accelerating cell death by triggering activation of proapoptotic host genes. PMN lysis and GAS virulence factors such as SpeB cause skeletal muscle
destruction and necrosis as seen by the downregulation of genes involved in skeletal muscle maintenance and integrity. Proteins encoded by upregulated NHP
genes are shown in red and downregulated genes in green. Proteins encoded by significantly upregulated GAS genes are shown in blue. AMP, antimicrobial
peptide; PRR, pattern recognition receptor; GAS, group A streptococcus; NLRP, NOD-like receptor; CR, complement receptor; FcR, immunoglobulin receptor;
TREM-1, triggering receptor expressed on myeloid cells; PGLYRP, peptidoglycan recognition protein; MPO, myeloperoxidase; BPI, bactericidal/permeability-
increasing protein; MYLK3, myosin light chain kinase; MYH6, myosin heavy chain; ACTN2, actinin, alpha; ACTA1, actin, alpha; TCAP, titin cap; GSN, gelsolin; DMD,
dystrophin; SGCB, sarcoglycan beta; EGF, epidermal growth factor; CTNNA3, catenin alpha; LAMA2, laminin subunit alpha; ADCY6, adenylate cyclase.
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With respect to metabolic adaptation, GAS genes encoding enzymes in the Embden-
Meyerhof-Parnas (glycolysis) pathway were downregulated in vivo whereas genes
encoding enzymes involved in transport and use of alternative carbon sources, such as
malate and ascorbate (which are abundant in host tissues) and maltose and glycerol,
were upregulated (Fig. S3A). Malate utilization is GAS is upregulated in vitro under
acidic stress conditions and in vivo in murine soft tissues (83, 84). This is consistent with
data from two recent studies reporting carbohydrate metabolism adaptation and
upregulation of production of certain virulence factors during GAS infection (54, 85).
Our data are also consistent with GAS undergoing a metabolic switch from homolactic
fermentation to mixed-acid fermentation (Fig. S3B).
We observed upregulation of an extracellular oxidative stress defense pathway that
uses cytoplasmic thioredoxin as a source of reducing power (Fig. S3C). Broadly similar
to a pathway reported for Streptococcus pneumoniae (86), this system is formed by the
thiol-disulfide oxidoreductases CcdA and TlpA and the bifunctional methionine sulfox-
ide reductase MsrA/B, which would protect GAS from the consequences of PMN
oxidative burst (87–89). This system may also contribute to GAS extracellular protein
folding (90). Importantly, proteins encoded by genes found to be upregulated during
infection in our study, including SpeB, SIC (streptococcal inhibitor of complement), and
HtpA, are detected in proteomic analyses from human patient samples (91). Taken
together, metabolic adjustments made by GAS to the host environment may assist the
organism to survive during infection of NHP skeletal muscle.
Our study also addressed a topic germane to many pathogenic microbes. Namely,
does a significant relationship exist between the magnitude of in vivo fitness and
differential regulation of pathogen genes? Previous studies addressing this matter have
yielded mixed results (67–69). For example, Turner et al. (68) compared RNA-seq and
Tn-seq data sets for P. aeruginosa and reported poor correlation between the two.
Comparison of the GAS RNA-seq data generated here with results obtained from a
previous genome-wide transposon mutagenesis screen in NHP necrotizing myositis
discovered a significant relationship between these two parameters. Our results con-
trast with (for example) those reported by Powell et al. (92), who studied the relation-
ship between Tn-seq and RNA-seq data for Snodgrassella alvi, a bacterial gut symbiont
in honey bees. The investigators found that there was a general lack (6% overlap) of a
significant relationship between the RNA-seq and Tn-seq data. One practical implica-
tion from our findings is that our multidimensional integrative strategy could be a
fruitful way to triage genes for future pathogenesis and translational research. That is,
selection of genes for analysis that are highly expressed and display significantly
decreased fitness when inactivated and studied in the environment of interest may
provide a productive way to discover new pathogenesis clues. Our results reported
here on dahA, ihk-irr, ciaH, isp, and slr provide a proof of principle for this concept and
thereby set the stage for additional studies, for example, on genes of unknown
function.
Compared to naturally occurring deep-tissue GAS infections in humans, this study
was performed under tightly controlled experimental conditions. We used a standard
infecting dose of GAS inoculated at the same anatomical site in the three NHPs, and the
host tissue samples were collected 24 h later (46, 55). Despite using a standardized
infection protocol, we observed some variation in differentially expressed GAS genes
between the three NHP hosts, primarily due to variation in the magnitude of fold
change in individual gene transcripts, rather than to the spectrum of differentially
expressed genes. Furthermore, our spatial (section-to-section) transcriptome analysis
yielded variability in gene expression contingent upon anatomic position with respect
to the inoculation site. This likely reflects the fact that necrotizing fasciitis/myositis
infection outcomes differ from host to host and from tissue to tissue within the same
host and might also differ from section to section within the same host tissue,
depending on bacterial load (CFU recovered), suggesting that population dynamics
and signaling might play a role. Here, we found that some GAS genes encoding or
involved in virulence factors, DNA and carbohydrate metabolism, cell wall biogenesis,
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and dissemination were differentially expressed depending on spatial location with
respect to the inoculation site. Importantly, we detected a GAS-associated immunologic
response with serum biomarkers in the host (either NHPs or human patients). The levels
of several of the tested serum biomarkers were significantly increased in both primate
hosts, suggesting that our NHP model of necrotizing myositis mimics the human
disease.
Our study used only one GAS strain, a serotype M1 organism that genetically
represents a pandemic clone that has emerged relatively recently (27). Given that GAS
is characterized by extensive genetic diversity, it is possible that other strains will differ
in transcriptome and virulence behavior. We used healthy adult NHPs in this study, with
no known immunologic defect. Many patients with GAS necrotizing infections have
underlying medical conditions that may influence pathogen-host interactions, includ-
ing disease character. Thus, it is likely that a more comprehensive understanding of the
molecular events involved in this devastating infection would require use of different
combinations of GAS strains, host infection sites, and experimental infection protocols.
MATERIALS AND METHODS
Bacterial strains and growth media. For in vitro growth, GAS strains were grown in Todd-Hewitt
broth (Becton, Dickinson [BD]) supplemented with 0.2% yeast extract (THY medium). This medium was
used (i) because it is a standard medium for GAS growth used by many investigators and (ii) because
there is no medium that adequately mimics in vivo conditions. THY medium was supplemented with
spectinomycin (150 g ml1) as needed. Escherichia coli strains were grown in Luria-Bertani (LB) medium
at 37˚C. LB medium was supplemented with spectinomycin (50 g ml1), as needed. Trypticase soy agar
supplemented with 5% sheep red blood cells (Becton, Dickinson and Co.) was also used for growth of
GAS strains. Spectinomycin dihydrochloride pentahydrate was purchased from Sigma. Gap electropora-
tion cuvettes (2-mm gap size) were purchased from BTX Harvard apparatus. Growth experiments were
performed as described previously (93). Locus tag equivalence between strains MGAS5005 and
MGAS2221 is shown in Table S1J in the supplemental material.
Ethics statement. All mouse and nonhuman primate studies were performed in accordance with
protocols AUP-0318-0016 and AUP-1217-0058 approved by the Institutional Animal Care and Use
Committee at the Houston Methodist Research Institute. All studies with human blood and blood
components were performed in accordance with a protocol (01-I-N055) approved for human subjects by
the Institutional Review Board at the National Institute of Allergy and Infectious Diseases. All study
volunteers gave written informed consent.
Nonhuman primate (NHP) skeletal muscle samples. We used a well-described NHP model of
necrotizing myositis (27, 45, 55). Three cynomolgus macaques (2.8 to 6.5 years of age, 2.9 to 3.5 kg of
body weight) were studied. Briefly, the animals were sedated, the injection site was marked, and 1  108
CFU/kg serotype M1 strain MGAS2221 was inoculated to uniform depths in the right thigh skeletal
muscle. Strain MGAS2221 was used because it has wild-type alleles (i.e., the most common allele) for all
major transcriptional regulators, because its genome has been sequenced, because it is genetically
representative of contemporary epidemic serotype M1 strains, and because it has been used extensively
in animal experiments (27). Animals were observed for 24 h and then subjected to necropsy. The infected
thigh muscle was removed en bloc, and a 0.5-cm full-thickness transverse section was cut through the
injection site with a TissueTek long trimming blade (Bevel). Infected tissue samples weighing 150 mg
were excised radially in concentric sections from the site of infection and submerged in 2 ml FastPrep
tubes (MP Biologicals, Inc.) containing 750 l of 1 RNA/DNA Shield (ZymoBIOMICS). The samples were
collected in duplicate. The sections were numbered 1 through 5, where section 1 corresponds to the
inoculation site and 5 to the section most distantly peripheral to the inoculation site (see Fig. S2A in the
supplemental material). As a negative control for GAS infection, uninfected skeletal muscle tissue was
collected from mock-infected animals given only the same volume of sterile phosphate-buffered saline
(PBS). Infected tissue was also collected for quantitative bacterial culture and histopathology examina-
tion.
RNA extraction from NHP tissue. Two sets of five contiguous tissue sections from the same NHP
(see Fig. S3 and S6A) were processed simultaneously. The tissue samples were thawed on ice, and sets
of two weighing dishes (24-mm and 85-mm inner base diameter) were wiped with RNaseZap (Invitro-
gen). The thawed tubes containing the tissue samples were weighed with a Sartorius Entris balance
(Fisher Scientific), the tissue was removed with a disposable spatula (VWR) and placed on the small
(24-mm-diameter) weighing dish which was then placed inside the larger (85-mm-diameter) dish. The
tissue was cut with a disposable scalpel (Exel International), and sections were placed on the larger
weighing dish and rubbed against the surface to eliminate excess liquid. The tissue (70 to 90 mg) was
washed twice by submerging it in an Eppendorf tube containing 1 ml PBS, gently inverted 10 times to
eliminate excess RNA Shield, and placed in a 15-ml Falcon tube (Ambion) containing 3 ml of tissue and
cell lysis solution, with 10 l of proteinase K (50 g/l) from a MasterPure complete DNA and RNA
isolation kit (Lucigen). Tissues were immediately homogenized (Omni tissue homogenizer; Omni Inter-
national) on ice at 35,000 rpm, using three bursts of 10 s each. The tubes were incubated at 65°C for
15 min, subjected to vortex mixing every 5 min, and kept on ice for 5 min. The lysate in each tube was
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transferred to precooled 2-ml tubes containing 0.1-mm-diameter and 0.5-mm-diameter beads (ZR
BashingBead lysis tubes; Zymo Research), and bead beating was performed at 1,600 rpm for 60 s and was
repeated twice. Between the two bead-beating steps, the tubes were centrifuged at 4°C and immediately
placed on ice. The tubes were centrifuged at 4°C at 13,000 rpm for 1 min, and the supernatant was
transferred to precooled 1.5-ml Eppendorf tubes. RNA was extracted (MasterPure complete DNA and
RNA purification kit; Lucigen) using the manufacturer’s instructions with the exception that the extracted
RNA was subjected to three consecutive DNase treatments with a Turbo DNA-free kit (Ambion) at 37°C.
RNA quality was assessed with an Agilent 6000 Nano kit (Agilent) and an Agilent 2100 Bioanalyzer. The
concentration of total RNA was determined with a Qubit RNA BR assay kit (Thermo Fisher Scientific).
Depletion of rRNA was performed with a Ribo-Zero Gold rRNA removal kit, epidemiology (Illumina). The
efficacy of the ribosomal depletion procedure was assessed with an RNA 6000 Pico kit (Agilent) and an
Agilent 2100 Bioanalyzer.
Gene coexpression network analysis. A weighted gene coexpression network analysis (WGCNA)
was performed on the normalized dual RNA-seq section data (n  15 samples) using the WGCNA R
software package (66, 94, 95). We largely followed the steps described in the tutorials available on the
WGCNA software home page (https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/Rpackages/
WGCNA/Tutorials/). To filter out genes expressed at low levels from the analysis, we included only those
genes whose normalized counts exceeded 20 in at least 40% of the samples. This resulted in a sample
consisting of 1,472 GAS genes and 3,020 NHP genes. The filtered data set was log transformed using
log2(x 	 1). To identify outliers, we performed a hierarchical cluster analysis. This revealed one obvious
outlier, which was removed from the data. The preprocessed data were split into a pathogen GAS data
set and a host NHP data set. We applied WGCNA on the two data sets, using Pearson correlation and the
signed hybrid option, to detect GAS- and NHP-specific clusters (or modules) of positively correlated
genes. The soft thresholding powers were chosen according to the approximate scale-free topology
criterion. The eigengene values of the modules were calculated, and modules were merged if the
correlation between their eigengene values exceeded 0.8. COG enrichment analysis of the GAS modules
was done in R using Fisher’s exact test and the Benjamini-Hochberg procedure. Pathogen-host interac-
tions were examined by correlating the eigengene values of the GAS and NHP modules.
Mouse virulence experiments with GAS isogenic mutant strains. Immunocompetent 5-week-old
female CD1 mice (Envigo Laboratories) were used for necrotizing myositis virulence studies as described
previously (45). Mice were randomly assigned to treatment groups and inoculated in the right hind limb
to a uniform depth with 7.5  106 CFU of isogenic mutant strain MGAS2221 ΔSpy0281 and wild-type
parental strain MGAS2221 in 100 ml PBS. Stocks of each strain were prepared at known CFU levels and
stored at – 80°C. Inocula were prepared by diluting frozen stocks in PBS to the desired number of CFU.
For survival experiments (n  20 mice/strain), near-mortality was determined by observation using
predefined criteria. For histology evaluation, lesions were excised, visually inspected, and photographed.
Histopathology was scored by a pathologist blind to the strain treatment groups as described previously
(27, 45). For the quantitative culture experiment (n  35 mice/strain for the wild-type and MGAS2221
ΔSpy0281 strains), limbs were homogenized (Omni International) and CFU counts were determined by
culturing serial dilutions. Identical methods were used to assess the virulence of all additional isogenic
deletion-mutant strains. All mouse experiments were approved by the Institutional Animal Care and Use
Committee of Houston Methodist Research Institute.
NHP virulence experiments with GAS isogenic mutant strains. The NHP model of necrotizing
myositis described above and elsewhere (27, 45, 55) was used. Each isogenic deletion-mutant strain was
given to four animals. Lesion volume, CFU recovery, and histopathology analyses were performed as
previously described (27, 45, 55). All NHP experiments were approved by the Institutional Animal Care
and Use Committee of Houston Methodist Research Institute.
GAS bactericidal activity assay. Bactericidal activity assays with human PMNs and GAS were
performed in accordance with protocol 01-I-N055, approved by the Institutional Review Board for human
subjects, National Institute of Allergy and Infectious Diseases. All volunteers gave written informed
consent prior to participation in the study. Human neutrophils were isolated from the venous blood of
healthy volunteers using a standard method (96). The wild-type MGAS2221 and isogenic MGAS2221
ΔSpy0281 deletion mutant strains were grown to early mid-exponential phase in THY medium with 5%
CO2 at 37°C (optical density at 600 nm [OD600]  0.5). A total volume of 600 l containing 106 PMNs,
106 bacteria, 10% autologous serum, and HEPES-buffered RPMI 1640 medium was dispensed into a
1.5-ml Eppendorf tube. Assay mixtures were rotated gently at 37°C for 1 or 3 h, at which time saponin
(0.1% final concentration) was added to each assay mixture and the tubes were placed on ice for 15 min.
An aliquot of each tube was diluted and plated on THY agar plates for enumeration of CFU. Percent GAS
survival was determined by comparison of CFU from assays performed with PMNs to CFU from assays
performed without PMNs. Data were analyzed with repeated-measures 1-way analysis of variance
(ANOVA) and Tukey’s posttest to correct for multiple comparisons (Prism 6 for Mac OS X, GraphPad Prism;
GraphPad Software Inc.).
Statistical analysis. Unless otherwise stated, error bars represent standard deviations (SD), and P
values were calculated using the Fisher exact test, the Mann-Whitney test, the Kruskal-Wallis test, or the
log rank test. Differential expression analysis was performed using DESeq2 1.16.1. Genes were considered
differentially expressed if the change in the level of expression was greater than 1.5-fold and was
associated with an adjusted P value (Bonferroni corrected) of 0.05. P values for pathways significantly
associated with the up- and downregulated host genes were computed by the use of Ingenuity pathway
analysis (IPA; version 01-14) with Fisher’s exact test. WGCNA was used with Pearson correlation and the
signed hybrid option to detect GAS- and NHP-specific clusters (or modules) of positively correlated
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genes. The soft thresholding powers were chosen according to the approximate scale-free topology
criterion. The eigengene values were calculated for the modules, and modules were merged if the
correlation between their eigengene values exceeded 0.8. The enrichment analyses of the modules were
done in R using Fisher’s exact test and the Benjamini-Hochberg procedure. For all animal experiments,
statistical testing was performed using GraphPad Prism (version 8.1.2). Nonparametric statistical tests
were used because the lesion volume and CFU data did not fit a normal distribution using the
Anderson-Darling test, the D’Agostino-Pearson test, the Shapiro-Wilk test, or the Kolmogorov-Smirnov
test. For mouse survival studies, results were graphed as Kaplan-Meier curves and data were analyzed
using the log rank test, with P values of 0.05 considered to be significant. For the mouse CFU
experiment, data were graphed as means  standard errors of the means (SEM) and analyzed using the
Mann-Whitney test, with P values of 0.05 considered to be significant. For the NHP virulence studies,
lesion volume and CFU data were graphed as means  SEM and analyzed using the Kruskal-Wallis test,
with P values of 0.05 considered to be significant.
Data availability. A slightly updated complete genome sequence of emm1 reference strain
MGAS2221 (GenBank accession number CP043530) has been deposited in the NCBI GenBank database
under the same accession number. Transcriptome data have been deposited in the Gene Expression
Omnibus under accession number GSE144100.
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